Biodimension Technology
We are suppored by the Best.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
* | $140k | Seed | |
| Total Funding | 000k | ||
Related Content
Biodimension Technology Private Limited, established in 2021, is a deep-tech biotechnology firm operating from Bengaluru, India. The company was founded by Manoj Kumar Sampath (CEO), Ranjith Kumar Velusamy (Chief Innovation Officer), and Pradeep Arunachalam (Chief Operating Officer). Biodimension focuses on developing and providing biofabricated human tissues as an alternative to animal testing for the pharmaceutical and cosmetic industries.
The company's core business involves leveraging advanced biofabrication and 4D bioprinting techniques to create functional replicas of human tissues. These tissue models offer a more ethical and human-relevant platform for testing the safety, toxicity, and efficacy of drugs, chemicals, and cosmetic products. By providing data that is more predictive of human responses compared to traditional animal models, Biodimension aims to de-risk and accelerate the drug discovery and development process. The high failure rate of drugs in clinical trials, despite promising results in animal studies, represents a significant market need that the company addresses.
Biodimension serves a business-to-business (B2B) client base, including biopharmaceutical and cosmetic companies. The company offers a range of products and services, including various biofabricated human tissue models like skin (epidermis and full-thickness), cornea, nasal, heart, and gingival tissues. It also provides customized tissue models, bio-organoid and tissue model-based drug screening services, and regulatory consultancy on non-animal testing methods. The firm has received support and incubation from institutions like Vellore Institute of Technology TBI and Sastra ABLEST. A significant milestone was achieved in October 2024, when the company secured ₹121 lakh in a funding round led by Campus Angels Network to enhance its cleanroom facilities and scale operations.
Keywords: biofabrication, human tissue models, animal testing alternatives, 3D bioprinting, drug screening, toxicity testing, preclinical studies, tissue engineering, organoids, cosmetic testing, pharmaceutical services, in-vitro testing, drug discovery, deep-tech, biotechnology, reconstructed human tissue, non-animal methods, regenerative medicine, personalized medicine, bioassays